While Multiple Myeloma can be deadly, research has helped prolong the lives of many people living with Multiple Myeloma.
More research is desperately needed to help give hope to people faced with a Multiple Myeloma diagnosis, particularly those at greater risk of succumbing to the disease.
Multiple Myeloma Support
Progressing research on the discovery of a unique protein that is overexpressed in 20-30% of Multiple Myeloma patients, with this group three-times more likely to die within six years of diagnosis.
Researcher
Dr Craig Wallington-Beddoe and collaborators are using this discovery to develop a way to quickly identify patients who express this protein so they can be given the most appropriate, available therapies right away, while also searching for new treatments.
Helping to control and improve the pain of myeloma patients who are treated with bortezomib, by understanding how changes in gut bacteria caused by bortezomib contribute to pain.
Researcher
Dr Hannah Wardill aims to improve outcomes for the one in five people with myeloma who are forced to stop taking bortezomib due to chronic pain.
